These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


292 related items for PubMed ID: 9055129

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Value of gadoxetic acid-enhanced and diffusion-weighted MR imaging in evaluation of hepatocellular carcinomas with atypical enhancement pattern on contrast-enhanced multiphasic MDCT in patients with chronic liver disease.
    Kim HS, Kim SH, Kang TW, Song KD, Choi D, Park CK.
    Eur J Radiol; 2015 Apr; 84(4):555-62. PubMed ID: 25617950
    [Abstract] [Full Text] [Related]

  • 23. Dysplastic nodules and hepatocellular carcinoma: thin-section MR imaging of explanted cirrhotic livers with pathologic correlation.
    Earls JP, Theise ND, Weinreb JC, DeCorato DR, Krinsky GA, Rofsky NM, Mizrachi H, Teperman LW.
    Radiology; 1996 Oct; 201(1):207-14. PubMed ID: 8816545
    [Abstract] [Full Text] [Related]

  • 24. Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade.
    Nasu K, Kuroki Y, Tsukamoto T, Nakajima H, Mori K, Minami M.
    AJR Am J Roentgenol; 2009 Aug; 193(2):438-44. PubMed ID: 19620441
    [Abstract] [Full Text] [Related]

  • 25. Nodule-in-nodule appearance of hepatocellular carcinomas: comparison of gadolinium-enhanced and ferumoxides-enhanced magnetic resonance imaging.
    Goshima S, Kanematsu M, Matsuo M, Kondo H, Kato H, Yokoyama R, Hoshi H, Moriyama N.
    J Magn Reson Imaging; 2004 Aug; 20(2):250-5. PubMed ID: 15269950
    [Abstract] [Full Text] [Related]

  • 26. Differentiation of well-differentiated hepatocellular carcinomas from other hepatocellular nodules in cirrhotic liver: value of SPIO-enhanced MR imaging at 3.0 Tesla.
    Park HS, Lee JM, Kim SH, Chang S, Kim SJ, Han JK, Choi BI.
    J Magn Reson Imaging; 2009 Feb; 29(2):328-35. PubMed ID: 19161184
    [Abstract] [Full Text] [Related]

  • 27. [The tissue characterization of focal liver lesions with magnetic resonance imaging].
    Manfredi R, Maresca G, De Gaetano AM, De Franco A, Marano P.
    Radiol Med; 1995 Sep; 90(3):250-61. PubMed ID: 7501830
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
    De Cobelli F, Castrucci M, Sironi S, Livraghi T, Venturini M, Salvioni M, Del Maschio A.
    Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
    Kim JE, Kim SH, Lee SJ, Rhim H.
    AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.